Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer appeals India patent office ruling
MarketWatch
Saturday, May 5, 2012 - 4:58pm
tags:
Bayer, patents, Nexavar, generics
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
PharmiWeb
Saturday, May 5, 2012 - 4:54pm
tags:
Tavaborole, Anacor, AN2728, atopic dermatitis, Onychomycosis, antifungals
Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Pharmabiz
Saturday, May 5, 2012 - 4:38pm
tags:
Pfizer, Quark Pharmaceuticals, Silence Therapeutics, PF-655, Open-Angle Glaucoma, diabetic macular oedema, AtuRNAi
Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Pharmalive
Saturday, May 5, 2012 - 4:33pm
tags:
Valeant Pharmaceuticals, AcneFree, University Medical
Phase I trial of novel HER2/neu Antigens will Start at Mayo; Isis Initiates Phase 2 Study of ISIS-APOCIIIRx
BioMedReports
Saturday, May 5, 2012 - 4:31pm
tags:
TapImmune, HER-2/neu vaccine, vaccines, Isis Pharmaceuticals, ISIS-APOCIIIRx, hypertriglyceridemia
Teva to Present New Data on Women's Health Products at the American Congress of Obstetricians and Gynecologists Annual Clinical Meeting
Sacramento Bee, CA
Saturday, May 5, 2012 - 2:14pm
tags:
Teva Pharmaceuticals, Plan B contraceptive, contraceptives
Apricus Biosciences Announces Poster Presentation of Femprox Phase III Clinical Data at American Urological Association Annual Meeting
Pharmalive
Saturday, May 5, 2012 - 2:12pm
tags:
Femprox, Apricus Biosciences, female sexual dysfunction
Pharma startup led by Lilly Ventures execs raises $4.6 million
MedCity News
Saturday, May 5, 2012 - 2:11pm
tags:
Esanex Inc, Lilly Ventures
Valeant posts 1Q loss on dermatology deal costs
Bioscience Technology
Saturday, May 5, 2012 - 1:58pm
tags:
Valeant Pharmaceuticals
Pfizer’s Lipitor Losing U.K. Patent Protection, the Times Says
Bloomberg
Saturday, May 5, 2012 - 1:03pm
tags:
Pfizer, Lipitor, patents
Earnings Scorecard: Bristol-Myers
Yahoo/Zacks
Saturday, May 5, 2012 - 1:02pm
tags:
Bristol-Myers Squibb, earnings
Abbott Labs Expands Pipeline
Yahoo/Zacks
Saturday, May 5, 2012 - 1:01pm
tags:
Abbott Laboratories
These 5 Big Healthcare Stocks Have Major Upside In 2013
Seeking Alpha
Saturday, May 5, 2012 - 12:58pm
tags:
Pfizer, Eli Lilly, Merck, Abbott Laboratories, PDL Biopharma
Will Abbott Labs Continue to Climb?
Motley Fool
Saturday, May 5, 2012 - 12:57pm
tags:
Abbott Laboratories
Pfizer Plan to Buy Stock, Raise Dividends Overshadows Growth Strategy
Minyanville
Saturday, May 5, 2012 - 12:42pm
tags:
Pfizer
Pfizer halts late-stage study into new Lyrica use
Yahoo/AP
Saturday, May 5, 2012 - 12:40pm
tags:
Pfizer, Lyrica, HIV neuropathy
Merck's Weak Pipeline Will Sink Stock By 2013
Seeking Alpha
Saturday, May 5, 2012 - 12:38pm
tags:
Merck, pipelines
Will Gilead Sciences Help You Retire Rich?
Motley Fool
Saturday, May 5, 2012 - 12:37pm
tags:
Gilead Sciences
Are Supply Troubles a Biotech Buying Opportunity?
Motley Fool
Saturday, May 5, 2012 - 12:36pm
tags:
ViroPharma, Cinryze
Gilead Sciences Inc (GILD): Today's Featured Health Care Loser
The Street
Saturday, May 5, 2012 - 12:35pm
tags:
Gilead Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.